Clinical Trial Update: Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rosuvastatin in Chinese patients with hyperlipidemia and atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Hyperlipidemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Hyperlipidemia, Atherosclerosis | Phase 4 | Status: UNKNOWN